Makes about A$1m a week in round figures. Just from royalties, currently only in USA. The license holder Acadia is expanding into Canada and Europe currently through regulators. It is barely 12 months since Daybue launched. It has about 900 sufferers on the treatment. There are estimated to be at least 5500+ sufferers in the US.
Neu is a business making profit. Daybue is a business. And the newly approved Phase 2 indications and more to follow are at least 5 times the market Daybue are targeting.
Neu is a profit making growth company in markets with no other approved treatments.
A MASSIVE moat.
Maybe you should read up on what you comment on.
NEU have $250m in the bank, no debt, and are profitable. Very profitable. With milestone payments to come as well.
Their expenses are bugger all. Until Phase 3’s arrive. And they have enough to fund 2 with cash on hand.
.
Share Price, page-10354
-
- There are more pages in this discussion • 616 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.090(0.46%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.55 | $19.65 | $18.88 | $10.53M | 549.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4552 | $19.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.30 | 674 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |